Home >  Investors Relations >  CryoLife's BioGlue Shown Effective in Pituitary Tumor Surgery

CryoLife to Present at 17th Annual Needham Healthcare Conference

March 20, 2018 at 8:04 AM EDT

ATLANTA, March 20, 2018 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 17th Annual Needham Healthcare Conference on Tuesday, March 27, 2018 at the Westin Grand Central in New York.

Cryolife logo. (PRNewsFoto/CryoLife, Inc.) (PRNewsFoto/CRYOLIFE_ INC_) (PRNewsFoto/CRYOLIFE, INC.)

A live webcast of the Company's presentation is scheduled to begin at 3:30 p.m. ET and will feature an overview of the company by Pat Mackin, Chairman, President and Chief Executive Officer.  

The live webcast can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page.  An archived copy of the webcast will be available for 90 days on the same website.

About CryoLife

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair.  CryoLife markets and sells products in more than 90 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com

Contacts:




CryoLife

The Ruth Group

D. Ashley Lee

Tram Bui / Emma Poalillo

Executive Vice President, Chief Financial Officer and

646-536-7035 / 7024

Chief Operating Officer

tbui@theruthgroup.com

Phone: 770-419-3355

epoalillo@theruthgroup.com



 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/cryolife-to-present-at-17th-annual-needham-healthcare-conference-300616346.html

SOURCE CryoLife, Inc.